M&A Deal Summary

Eurobio Scientific Acquires GenDx

On October 3, 2022, Eurobio Scientific acquired software company GenDx from Ampersand Capital Partners for 135M EUR

Acquisition Highlights
  • This is Eurobio Scientific’s 1st transaction in the Software sector.
  • This is Eurobio Scientific’s 0th largest (disclosed) transaction.
  • This is Eurobio Scientific’s 1st transaction in the Netherlands.

M&A Deal Summary
Date 2022-10-03
Target GenDx
Sector Software
Buyer(s) Eurobio Scientific
Sellers(s) Ampersand Capital Partners
Deal Type Add-on Acquisition
Deal Value 135M EUR

Target

GenDx

Utrecht, Netherlands
GenDx is a Dutch company specializing in Molecular Diagnostics, focused on the development, production, and sales of innovative assays and analysis software for transplantation and companion diagnostics. GenDx specializes in HLA sequencing-based typing strategies and offers reagents and software for both Sanger and NGS approaches. GenDx was founded in 2005 and is based in Utrecht, Netherlands.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Eurobio Scientific

Les Ulis, France
Category Company
Founded 1997
Sector Healthcare Services
Employees300
Revenue 131M EUR (2023)
DESCRIPTION

Eurobio Scientific is involved in the manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology, and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, the group has established its own distribution network and a portfolio of proprietary products in the molecular biology field. Eurobio was founded in 1997 and is based in Les Ulis, France.

DEAL STATS #
Overall 2 of 3
Sector (Software) 1 of 1
Type (Add-on Acquisition) 2 of 3
Country (Netherlands) 1 of 1
Year (2022) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-13 Biomedical Diagnostics

Antwerpen, Belgium

Biomedical Diagnostics (BMD) is a Belgian company marketing specialty tests for medical diagnostics. The company has become over the years a pure distribution company, representing high-quality partners and products in niche sectors of in vitro diagnostics. It provides appropriate solutions and personalized services to all clinical biology laboratories in Belgium, Luxembourg and the Netherlands. Biomedical Diagnostics was formed in 1986 and is based in Antwerpen, Belgium.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-06-13 Diagnostic International Distribution

Milan, Italy

Diagnostic International Distribution offers a range of specialized tests and instruments through exclusive distribution agreements. DID currently markets specific products from the Eurobio Scientific group by distributing the EurobioPlex range of PCR tests for infectious diseases. Diagnostic International Distribution was formed in 1946 and is based in Milan.

Buy -

Seller(S) 1

SELLER

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 53 of 55
Sector (Software) 2 of 2
Type (Add-on Acquisition) 38 of 38
Country (Netherlands) 1 of 1
Year (2022) 6 of 7
Size (of disclosed) 7 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-28 iuvo

Rush, New York, United States

iuvo is a partner research organization (PRO) serving the medical device and pharmaceutical industries. iuvo offers technical and regulatory consulting services, contract laboratory services, and contract sterilization out of its two locations, in Rush, New York, and Erie, Pennsylvania. iuvo was founded in 1978 and is based in Rush, New York.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-08 Alcami

Wilmington, North Carolina, United States

Alcami is a fully-integrated end-to-end contract development and manufacturing organization. Alcami serves pharmaceutical and biotech companies of all sizes providing customizable and innovative solutions for analytical development, clinical to commercial sterile and oral solid manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring, and pharmaceutical support services. Alcami was founded in 1979 and is based in Wilmington, North Carolina.

Sell -
Mergr

Product

Company

Legal